What is the equity of Epigenomics this year?
Epigenomics has equity of 10.17 M EUR this year.
Epigenomics Equity 2024
Epigenomics Equity
10.17 M EUR
Ticker
ECX.DE
ISIN
DE000A3H2184
WKN
A3H218
In 2024, Epigenomics's equity was 10.17 M EUR, a -54.01% increase from the 22.12 M EUR equity in the previous year.
Epigenomics Aktienanalyse
What does Epigenomics do?
Epigenomics AG is a German biotechnology company specializing in the development of diagnostics for the early detection of cancer. The company is headquartered in Berlin and was founded in 1997. Epigenomics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Epigenomics's Equity
Epigenomics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Epigenomics's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Epigenomics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Epigenomics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Epigenomics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Epigenomics Stock
What was the equity of Epigenomics compared to the previous year?
The equity of Epigenomics has increased/decreased by -54.01% decreased compared to the previous year.
What impact does a high equity have on investors of Epigenomics?
A high equity is advantageous for investors of Epigenomics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Epigenomics?
A low equity can be a risk for investors of Epigenomics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Epigenomics affect the company?
An increase in equity of Epigenomics can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Epigenomics affect the company?
A reduction in equity of Epigenomics can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Epigenomics?
Some factors that can affect the equity of Epigenomics include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Epigenomics so important for investors?
The equity of Epigenomics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Epigenomics take to change the equity?
To change equity, Epigenomics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Epigenomics pay?
Over the past 12 months, Epigenomics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Epigenomics is expected to pay a dividend of 0 EUR.
What is the dividend yield of Epigenomics?
The current dividend yield of Epigenomics is .
When does Epigenomics pay dividends?
Epigenomics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Epigenomics?
Epigenomics paid dividends every year for the past 0 years.
What is the dividend of Epigenomics?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Epigenomics located?
Epigenomics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Epigenomics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Epigenomics from 6/15/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/15/2024.
When did Epigenomics pay the last dividend?
The last dividend was paid out on 6/15/2024.
What was the dividend of Epigenomics in the year 2023?
In the year 2023, Epigenomics distributed 0 EUR as dividends.
In which currency does Epigenomics pay out the dividend?
The dividends of Epigenomics are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Epigenomics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Epigenomics
Our stock analysis for Epigenomics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Epigenomics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
